Schedule 13D ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2015-12-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,832,910
Percent of class
28.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-088583
Form type
SC 13D/A
Filer
Children's Hospital of Philadelphia Foundation
CIK
CIK 1632060
Filed
Jan 07, 2016
Reporting period
Dec 28, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub